Immunocore Holdings Plc (IMCR)
27.90
-0.62
(-2.17%)
USD |
NASDAQ |
Jun 10, 16:00
27.94
+0.04
(+0.14%)
After-Hours: 20:00
Immunocore Holdings SG&A Expense (Quarterly) : 37.79M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 37.79M |
| December 31, 2025 | 42.58M |
| September 30, 2025 | 39.53M |
| June 30, 2025 | 43.30M |
| March 31, 2025 | 40.35M |
| December 31, 2024 | 41.93M |
| September 30, 2024 | 35.90M |
| June 30, 2024 | 38.68M |
| March 31, 2024 | 39.26M |
| December 31, 2023 | 41.81M |
| September 30, 2023 | 25.67M |
| June 30, 2023 | 35.12M |
| Date | Value |
|---|---|
| March 31, 2023 | 32.86M |
| December 31, 2022 | 50.60M |
| September 30, 2022 | 13.71M |
| June 30, 2022 | 23.60M |
| March 31, 2022 | 26.96M |
| December 31, 2021 | 32.84M |
| September 30, 2021 | 27.62M |
| June 30, 2021 | 33.29M |
| March 31, 2021 | 27.83M |
| December 31, 2020 | 18.71M |
| December 31, 2019 | 11.03M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Silence Therapeutics Plc | 7.026M |
| NuCana Plc | 2.113M |
| Mereo BioPharma Group Plc | 4.012M |
| Compass Pathways Plc | 16.40M |
| Genflow Biosciences Plc | -- |